
News|Videos|February 7, 2021
CAEL-101 is Effective and Safe for the Treatment of Amyloid Light Chain Amyloidosis
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about what CAEL-101 is, how it works, and how it is used to treat patients with amyloid light chain amyloidosis.
Advertisement
Pharmacy Times® interviewed Jason Valent, MD, of the Cleveland Clinic about what CAEL-101 is, how it works, and how it is used to treat patients with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62nd American Society of Hematology Annual Meeting & Exposition.
The full conversation can be found in the video above.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
2
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
3
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
4
Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure
5









































































































































































































